Multiple sclerosis: 2024 update

Multiple sclerosis: 2024 update

Multiple sclerosis (MS) is a complex immune-mediated disease that leads to neurological disability, with ongoing challenges in understanding its initiation, predicting progression, and optimizing personalized treatment. This review article summarizes key research findings from 2024, covering advanc...

Full description

Saved in:

Bibliographic Details
Main Authors:	Luisa Klotz, Maija Saraste, Laura Airas, Tanja Kuhlmann
Format:	Article
Language:	English
Published:	University of Münster / Open Journals System 2025-07-01
Series:	Free Neuropathology
Subjects:	Multiple sclerosis Genetics Disease course Diagnostic criteria Biomarkers Imaging
Online Access:	https://www.uni-muenster.de/Ejournals/index.php/fnp/article/view/6762
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ATYPICAL FORMS OF MULTIPLE SCLEROSIS IN THE TOMSK REGION
by: V. M. Alifirova, et al.
Published: (2013-10-01)

Osteopontin as a diagnostic and NTZ-response biomarker of multiple sclerosis: a systematic review and meta-analysis
by: Adela González-Jiménez, et al.
Published: (2025-06-01)

Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosis
by: Nylund Marjo, et al.
Published: (2025-08-01)

A rare case of the late onset of Balo concentric sclerosis
by: V. A. Shidlovsky, et al.
Published: (2024-10-01)

Validation of a Set of Clinical Criteria for the Diagnosis of Secondary Progressive Multiple Sclerosis
by: Alin Ciubotaru, et al.
Published: (2024-11-01)

Magnetic Resonance Imaging in Multiple Sclerosis: An Analysis of the Implementation of the Portuguese Consensus
by: Ricardo Soares dos Reis, et al.
Published: (2025-07-01)

Blood serum 48 kDa form of unconventional myosin 1c characterizes the early stage of multiple sclerosis
by: N. O. Nehrych, et al.
Published: (2018-07-01)

The central vein sign in the diagnosis of multiple sclerosis
by: Sh. R. Nabiev, et al.
Published: (2024-04-01)

Analysis of probable predictors of aggressive multiple sclerosis
by: N. N. Spirin, et al.
Published: (2020-01-01)

Family case of multiple sclerosis in Perm Region
by: T. V. Zavalina, et al.
Published: (2009-02-01)

Integrated transcriptomics of multiple sclerosis peripheral blood mononuclear cells explored potential biomarkers for the disease
by: Arman Mokaram Doust Delkhah
Published: (2025-06-01)

Multiple sclerosis: disease modifying therapy and the human leukocyte antigen
by: Lineu Cesar Werneck, et al.

Neuropathic pain in multiple sclerosis: serum biomarkers and MRI lesion localization
by: Mohamed Hamdy Ismail, et al.
Published: (2025-04-01)

Challenges in Adherence to Magnetic Resonance Imaging Consensus Recommendations in Multiple Sclerosis: A Call for Improved Neurologist-Neuroradiologist Collaboration
by: Mafalda Soares, et al.
Published: (2025-08-01)

Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra
by: A. A. Sokolova, et al.
Published: (2024-06-01)

A study of patients with aggressive multiple sclerosis at disease onset
by: Kaunzner U, et al.
Published: (2016-08-01)

HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysisResearch in context
by: Brian C. Zhang, et al.
Published: (2025-08-01)

Multiple sclerosis and pregnancy. Impact of multiple sclerosis disease-modifying therapy on the health of newborns
by: T. I. Yakushina
Published: (2021-02-01)

Biomarker Identification in Patients with Multiple Sclerosis Treated with Autologous Hematopoietic Stem Cell Transplantation
by: Moisés Manuel Gallardo-Pérez, et al.
Published: (2025-03-01)

The clinical-radiological paradox in multiple sclerosis: myth or truth?
by: Ana Hartmann, et al.
Published: (2023-01-01)

Biomarker combinations from different modalities predict early disability accumulation in multiple sclerosis
by: Vinzenz Fleischer, et al.
Published: (2025-01-01)

Gene- Vitamin D Interaction and Multiple Sclerosis
by: J Gordon Millichap
Published: (2010-07-01)

Malignant multiple sclerosis: clinical and demographic prognostic factors
by: Fabrício Hampshire-Araújo, et al.

Role of soluble biomarkers in treating multiple sclerosis and neuroinflammatory conditions
by: Gauruv Bose, et al.
Published: (2025-07-01)

Current challenges in secondary progressive multiple sclerosis: diagnosis, activity detection and treatment
by: Luis Brieva, et al.
Published: (2025-03-01)

Ageing and multiple sclerosis
by: Julija Isačenko, et al.
Published: (2024-12-01)

Neurocardiology Update: The Brain–Heart Connection in Multiple Sclerosis—A Narrative Review
by: Nicoleta Gherghel‐Pavăl, et al.
Published: (2025-03-01)

Polymorphisms in the CIITA −168A/G (rs3087456) and CIITA +1614G/C (rs4774) may influence severity in multiple sclerosis patients
by: Valéria Coelho Santa Rita Pereira, et al.

The role of microglia in multiple sclerosis: implications for treatment with Bruton’s tyrosine kinase inhibitors
by: Patrick Vermersch, et al.
Published: (2025-05-01)

PSEUDOTUMORAL FORM OF MULTIPLE SCLEROSIS WITH SYMPTOMATIC CONVULSIVE SEIZURES (A CLINICAL CASE)
by: Yu. A. Belova, et al.
Published: (2016-01-01)

Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis
by: A. N. Boyko, et al.
Published: (2019-11-01)

Longitudinal Trend Monitoring of Multiple Sclerosis Ambulation Using Smartphones
by: Andrew P. Creagh, et al.
Published: (2022-01-01)

Optimization of therapy in secondary progressive multiple sclerosis
by: A. N. Boyko, et al.
Published: (2024-08-01)

The impact of changing diagnostic criteria on disability in a Brazilian multiple sclerosis cohort
by: Felipe Toscano Lins de Menezes, et al.
Published: (2025-06-01)

Quality of Life in Patients with Multiple Sclerosis
by: Grażyna Franek, et al.
Published: (2019-06-01)

Editorial: Neuroanatomical and molecular biomarkers for multiple sclerosis progression and therapeutic response
by: Ignacio Casanova, et al.
Published: (2025-06-01)

Paramyxoviruses and Multiple Sclerosis
by: Baghdad Science Journal
Published: (2012-09-01)

Olfactory alterations in patients with multiple sclerosis
by: Sergio Semeraro Jordy, et al.

Does Age at Menarche Differ Between Patients With Multiple Sclerosis and Healthy Controls?: An Updated Systematic Review and Meta-Analysis
by: Zahra Shahraki, et al.
Published: (2025-04-01)

Possible roles of sestrin2 in multiple sclerosis and its relationships with clinical outcomes
by: Faruk Omer ODABAS, et al.
Published: (2022-02-01)